The world is facing a global shortage of medical oxygen. Alongside corticosteroids, medical oxygen is the only proven lifesaving treatment for the most seriously ill COVID-19 patients. Without oxygen, COVID-19 patients suffering from hypoxemia – an abnormally low level of oxygen in the blood – will likely die.
The Global Fund and partners are supporting countries to access medical oxygen products – including through partnerships such as the COVID-19 Oxygen Emergency Taskforce, part of the Therapeutics Pillar of the Access to COVID-19 Tools Accelerator (ACT-Accelerator).
The emergence and circulation of new variants of COVID-19 highlight the urgent need to stop the spread of the pandemic everywhere. The Global Fund is encouraging countries to apply for fast-track funding through its COVID-19 Response Mechanism, for the response to the pandemic. The funding includes support to procure diagnostic tests, personal protective equipment (PPE), and treatments – such as corticosteroids and medical oxygen.
COVID-19 is causing a devastating oxygen crisis download in English | Français
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website.
To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.